Sentinel lymph node biopsy in breast cancer--experience with the combined use of dye and radioactive tracer at Aarhus University Hospital

Autor: Jens Peter Garne, Peer Christiansen, Anders Lernevall, Flemming Brandt Sørensen, Flemming Melsen, Mette Cathrine Lauridsen
Jazyk: angličtina
Rok vydání: 2004
Předmět:
Patent Blue V
Cohort Studies
chemistry.chemical_compound
Frozen Sections
Coloring Agents
Ultrasonography
Aged
80 and over

medicine.diagnostic_test
Micrometastasis
Hematology
General Medicine
Middle Aged
Prognosis
Immunohistochemistry
medicine.anatomical_structure
Oncology
Lymphatic Metastasis
Female
Radiology
Adult
medicine.medical_specialty
Axillary lymph nodes
Sentinel lymph node
Breast Neoplasms
Risk Assessment
Sensitivity and Specificity
Breast cancer
Predictive Value of Tests
Biopsy
Preoperative Care
medicine
Humans
Radiology
Nuclear Medicine and imaging

Neoplasm Invasiveness
Radionuclide Imaging
Aged
Neoplasm Staging
Retrospective Studies
Radioisotopes
Intraoperative Care
business.industry
Sentinel Lymph Node Biopsy
Axillary Lymph Node Dissection
medicine.disease
Surgery
Axilla
chemistry
Lymph Nodes
business
Zdroj: Lauridsen, M C, Garne, J P, Sørensen, F B, Melsen, F, Lernevall, A & Christiansen, P 2004, ' Sentinel lymph node biopsy in breast cancer--experience with the combined use of dye and radioactive tracer at Aarhus University Hospital. ' Acta Oncologica, vol. 43, no. 1, pp. 20-6 .
Lauridsen, M C, Garne, J P, Sørensen, F B, Melsen, F, Lernevall, A & Christiansen, P 2004, ' Sentinel lymph node biopsy in breast cancer--experience with the combined use of dye and radioactive tracer at Aarhus University Hospital ', Acta Oncologica, bind 43, nr. 1, s. 20-26 .
Aarhus University
Popis: One hundred and twenty-four patients with palpable tumours underwent sentinel lymph node biopsy (SLNB) and subsequent axillary lymph node dissection. Ultrasound of the axilla was used as part of the diagnostic work-up on all patients and those with lymph node metastasis verified by fine-needle aspiration biopsy (FNAB) were not included. For identifying the SLNs, a combination of Tc-99m-labelled human albumin (Solco-ALBU-RES) and blue dye (Patent Blue V) was used. No lymphoscintigraphy was performed. The SLN was successfully identified in 122 out of 124 (98%) patients and 66 (54%) patients were found to have metastatic involvement of the axillary lymph nodes. In 52 (79%) of these patients, the SLNs were the only nodes involved, 28 (54%) had micrometastasis only. The false-negative rate was 1.5%. This method has proven valid in the staging of the axilla in patients with breast cancer. The advanced techniques of serial sectioning and immunohistochemical staining further improve the diagnostic advantage offered by the SLNB, as it increases the possibility of diagnosing micrometastatic deposits. Udgivelsesdato: 2004-null
Databáze: OpenAIRE